ID   UKRV-Mel-20e
AC   CVCL_C403
DR   cancercelllines; CVCL_C403
DR   Cosmic; 1846712
DR   Cosmic; 2686525
DR   ESTDAB; ESTDAB-235
DR   Wikidata; Q54990612
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-235
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D3S1358: 16,17
ST   D5S818: 12,14
ST   D7S820: 10,12
ST   FGA: 21,25
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A721 ! UKRV-Mel-20a
OI   CVCL_C401 ! UKRV-Mel-20b
OI   CVCL_C402 ! UKRV-Mel-20c
OI   CVCL_C404 ! UKRV-Mel-20f
OI   CVCL_C405 ! UKRV-Mel-20h
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
RX   PubMed=23348503; DOI=10.1126/science.1230062;
RA   Horn S., Figl A., Rachakonda P.S., Fischer C., Sucker A., Gast A.,
RA   Kadel S., Moll I., Nagore E., Hemminki K., Schadendorf D., Kumar R.;
RT   "TERT promoter mutations in familial and sporadic melanoma.";
RL   Science 339:959-961(2013).
//